Kineon MOVE+ Pro Review: Price, Tested Output and FDA Status

We have no paid relationship with Kineon today. The buttons on this page go through a MoveWell link so we can count clicks.

Last verified November 1, 2026. Price and specs were checked on kineon.io that day. FDA status comes from FDA GUDID data via beudamed.com. We haven't measured this device ourselves.

Verdict

Verdict: The MOVE+ Pro straps red LEDs and 808 nm laser diodes directly onto a joint, which is closer to how the knee pain trials worked than a panel at a distance. A 2024 conference test found it matched its specs. It's an exempt heating-lamp listing, not an FDA-cleared device, and its per-session dose is probably below what the knee trials used. Worth a look if you want to target one joint.

Who it's for and who it isn't

• For: one sore joint, especially a knee, where you want light on the skin rather than from a panel.
• Not for: large areas, skin or hair.
• Not for: anyone with an undiagnosed joint problem; get it checked first.

Price (checked November 1, 2026)

$399 on kineon.io, marked down from $699 in an early Black Friday sale¹. Warranty: 1 year. Kineon offers a 30-day trial; its FAQ ties the money-back guarantee to 3 to 4 weeks of daily use.

Verified specs and output

• Wavelengths: 660 nm red LEDs and 808 nm near-infrared laser diodes¹.
• Light sources: three modules, each with 8 red LEDs (20 mW each) and 10 Class 1 laser diodes (5 mW each), per Kineon¹.
• Measured output: a 2024 conference paper that tested seven devices by spectroradiometry found the Kineon MOVE+ matched its specs. It isn't peer reviewed, and the summary gives no figures³.
• Treatment area: Kineon gives module size (59 × 37 mm, two emission areas each), not a treated area or mW/cm².
• Schedule: 10 to 15 minutes daily, at most twice a day, per the FAQ¹; other parts of the page say 5 minutes.

FDA status

GUDID data list a KINEON device (model XG-01B, made by Shenzhen Kaiyan Medical Equipment) under product code ILY, "Lamp, Infrared, Therapeutic Heating", exempt from premarket submission, with no 510(k) number². Infrared heating lamps are Class II but exempt from review⁴. Kineon's product page makes no FDA claim. Some reviews describe the device as FDA-cleared; we found no clearance.

What the evidence supports

Knee osteoarthritis pain is grade B: a meta-analysis of 22 placebo-controlled trials found pain fell 18.7 mm more than placebo on a 100 mm scale at recommended doses, which were 4 to 8 J per spot at 785 to 860 nm⁵. The MOVE+'s 808 nm is in that range. By our arithmetic, one 5 mW laser diode delivers about 3 J in 10 minutes, below the trials' range, though a diode isn't the same as a treated spot, so treat that as a rough guide. Muscle recovery trials (grade B−) also used light on the skin⁶. See the evidence map.

Pros and cons

Pros

• On-skin lasers at a wavelength the knee trials used.
• Matched its specs in a 2024 independent test.

Cons

• Not FDA-cleared.
• Probably a low dose per session compared with the trials.
• 1-year warranty.
• Conflicting session times on the product page.

Alternatives

• Mito Red Light: a panel with lab-measured output for larger areas.
• Hooga: a cheaper small panel, without verified output.

FAQ

Is Kineon FDA-cleared?

We found no clearance. GUDID data list a Kineon device as an exempt infrared heating lamp.

Does it work for knee pain?

Laser therapy for knee osteoarthritis has grade B evidence from clinic lasers. No trial has tested the MOVE+ itself.

Can I use it more than twice a day?

Kineon says no more than twice a day. Light therapy shows a biphasic dose response, so more isn't better.

References

1. Kineon. MOVE+ Pro product page: price, LEDs, lasers, wavelengths, power, schedule, warranty and trial. Checked 1 November 2026. Source
2. beudamed.com mirror of FDA GUDID data: KINEON XG-01B, product code ILY, premarket exempt. Source
3. Light Therapy Insiders. Summary of an MHSRS 2024 conference paper that tested seven photobiomodulation devices by spectroradiometry (not peer reviewed). Source
4. 21 CFR 890.5500, Infrared lamp: Class II, exempt from premarket notification when it is an infrared therapeutic heating lamp. Source
5. Stausholm MB, et al. Efficacy of low-level laser therapy on pain and disability in knee osteoarthritis: systematic review and meta-analysis of randomised placebo-controlled trials. BMJ Open, 2019;9(10). Source
6. Oliveira ACAS, et al. Does photobiomodulation improve muscle performance and recovery? A systematic review. Revista Brasileira de Medicina do Esporte, 2023;29. Source